Industry, equipment vendors, and regulators are busy refining the precision and reliability of dissolution testing. Solid dosage formulators rely on dissolution testing to mechanically model the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...

US Pharmacopeia apparatuses for testing the dissolution of transdermal drugs produce good, reproducible results. Yet some scientists believe that further modifications could improve the instruments?

WEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a ...

Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, it is important that ...

Pharmaceutical testing is a must to ensure that all medications meet the top quality, safety, and performance requirements before they enter the market. CD Formulation’s cGMP-compliant laboratory is ...

Agilent Technologies Inc. has introduced the 280-DS Mechanical Qualification System, a new instrument for routine and effortless calibration of a dissolution apparatus. The 280-DS accurately measures, ...

Mark Hammond, Business Development Manager of Melbourn Scientific has explained that a large number of the more recent active ingredients are poorly soluble in traditional media and expose the ...

The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...

NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- During the forecast period 2023-2033, the pharmaceutical dissolution testing services market is expected to grow at a value of 8.3% CAGR, according to ...